Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kessler

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
HCA Healthcare Journal of Medicine|May 20, 2026
Resident Scholarly Activity Plan and Scorecard Implementation in Graduate Medical EducationMichele L McCarroll, Afsha Rais Kaisani, Joseph Kessler, et al.
Biopreservation and Biobanking|June 24, 2014
Viable mononuclear cell stability study for implementation in a proficiency testing program: impact of shipment conditionsOlga A Kofanova, Kristine Davis, Barbara Glazer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 5, 2025
Core Interventions for the Prevention of Peritoneal Dialysis Related InfectionsJeffrey Perl, Isaac Teitelbaum, Bradley A Warady, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18Dennis Dias, Jeff Van Doren, Sonela Schlottmann, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneShrenik K Shah, Natalie Chen, Ravindra N Guthikonda, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic propertiesDooseop Kim, Liping Wang, Jeffrey J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidinesChristopher L Lynch, Amy L Gentry, Jeffrey J Hale, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
HCA Healthcare Journal of Medicine|May 20, 2026
Resident Scholarly Activity Plan and Scorecard Implementation in Graduate Medical EducationMichele L McCarroll, Afsha Rais Kaisani, Joseph Kessler, et al.
Biopreservation and Biobanking|June 24, 2014
Viable mononuclear cell stability study for implementation in a proficiency testing program: impact of shipment conditionsOlga A Kofanova, Kristine Davis, Barbara Glazer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 5, 2025
Core Interventions for the Prevention of Peritoneal Dialysis Related InfectionsJeffrey Perl, Isaac Teitelbaum, Bradley A Warady, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18Dennis Dias, Jeff Van Doren, Sonela Schlottmann, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneShrenik K Shah, Natalie Chen, Ravindra N Guthikonda, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic propertiesDooseop Kim, Liping Wang, Jeffrey J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidinesChristopher L Lynch, Amy L Gentry, Jeffrey J Hale, et al.
Pageof 2